Evidence map›Paper›PMID 41990307›Full record

ArticleNeurology2026

Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic.

Colin Groot, Ismael L Calandri, Ilse Bader, Diana I Bocancea, Hannah de Bruin, Maria Carrigan, Lyduine E Collij, Flora H Duits, Suzie Kamps, Lotte A de Koning and 20 more

Abstract read
In one paragraph

Article in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Colin GrootAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0002-5802-6946
Ismael L CalandriAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.
Ilse BaderAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0009-0009-6670-9569
Diana I BocanceaAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.
Hannah de BruinAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0002-9011-1120
Maria CarriganAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0009-0001-3506-9708
Lyduine E CollijAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0000-0001-6263-1762
Flora H DuitsAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0002-3436-1125
Suzie KampsAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0009-0009-4264-3040
Lotte A de KoningAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0009-0007-9325-4745
Afina W LemstraAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0002-8933-3260
Sophie E MastenbroekAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0009-0006-2759-9588
Roos M RikkenAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0000-0002-1357-2572
Bastiaan G J van TolAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0009-0003-0217-1786
Marie R VermeirenAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0009-0007-6876-5770
Alex WesselingAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.
Ye XiaAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.
Charlotte E TeunissenAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0000-0002-4061-0837
Elsmarieke van de GiessenAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0000-0001-9956-4233
Frederik BarkhofAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0000-0003-3543-3706
Laura E JonkmanAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0000-0003-1479-3649
Casper de BoerAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0001-6002-0749
Annemieke J RozemullerAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0000-0003-2528-4428
Anna E LeeuwisAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.
Annelies E van der VliesAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0009-0004-1374-3222
Betty M TijmsAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0002-2612-1797
Wiesje M van der FlierAmsterdam Neuroscience, Neurodegeneration, the Netherlands.ORCID 0000-0001-8766-6224
Yolande A L PijnenburgAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0003-2464-1905
Emma M CoomansAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0002-4289-9101
Rik OssenkoppeleAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands.ORCID 0000-0003-1584-7477

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesLimbic-predominant age-related TDP-43 encephalopathy (LATE) is characterized by an amnestic- and limbic-predominant phenotype, which can mimic Alzheimer disease (AD). In a memory clinic cohort, we tested whether clinical criteria for LATE can detect a clinical profile of LATE that is distinct from AD.

methodsIn this retrospective examination of a longitudinal memory clinic cohort from the Alzheimer Center Amsterdam, we included individuals with mild cognitive impairment (MCI) and dementia (aged >50 years). We classified individuals based on baseline data on cognition, atrophy, amyloid-status, and tau-status into Probable- and Possible-LATE, co-occurring LATE and AD (LATE-AD), and AD (without LATE). Next, we compared these groups on demographics, clinical features, cognition, and atrophy.

resultsOf 3,606 individuals (mean age at baseline 66 [SD 6], 49.2% female) available for classification, we classified 56 (1.6%) as Probable-LATE, 115 (3.2%) as Possible-LATE, 127 (3.5%) as LATE-AD, and 1,675 (46.5%) as AD. Individuals with Probable-LATE progressed slower than AD on mini-mental state examination (MMSE) (sβ [SE] = 0.12 [0.05], DISCUSSION: Using an operationalization of clinical criteria for LATE, 8.2% of participants with MCI or dementia from our tertiary memory clinic were classified as Possible-LATE, Probable-LATE, or LATE-AD. Probable-LATE was characterized by a milder disease course than AD, whereas LATE-AD was characterized by a more aggressive disease course. This underscores the value of the proposed clinical criteria in identifying individuals with suspected LATE, who have distinct clinical trajectories from AD. Our findings, therefore, support the use of these criteria to improve diagnostic and prognostic accuracy in the memory clinic.

Indexed as

Alzheimer DiseaseCognitive DysfunctionTDP-43 ProteinopathiesAgedAtrophyDementiaDisease ProgressionFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsRetrospective Studies

Identifiers

PMID41990307
PMCPMC13089194

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.